TAILIEUCHUNG - Báo cáo y học: "Tako-tsubo cardiomyopathy after administration of ergometrine following elective caesarean delivery: a case repor"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Tako-tsubo cardiomyopathy after administration of ergometrine following elective caesarean delivery: a case report. | Keskin et al. Journal of Medical Case Reports 2010 4 280 http content 4 1 280 jAg JOURNALOF medical ÌỤr case REPORTS CASE REPORT Open Access Tako-tsubo cardiomyopathy after administration of ergometrine following elective caesarean delivery a case report Abdulgazi Keskin Ralph Winkler Bernd Mark Andreas Kilkowski Timm Bauer Oliver Koeth Selcan Camci Bernd Cornelius Gunther Layer Uwe Zeymer Ralf Zahn Abstract Introduction Tako-tsubo cardiomyopathy stress-induced cardiomyopathy or transient left ventricular ballooning is characterized by clinical suspicion of an acute myocardial infarction with transient apical or midventricular dyskinesia of the left ventricle without significant coronary stenosis on angiography. The etiology of this disease remains obscure. One of the possible causes is myocardial ischemia induced by coronary vasospasm due to sympathetic activation. It has been hypothesized that the application of ergometrine could induce tako-tsubo cardiomyopathy. Case presentation We report the case of a 28-year-old Turkish woman who developed tako-tsubo cardiomyopathy after administration of ergometrine for release of placenta and prevention of bleeding during the post-partum phase in the course of an elective caesarean delivery. Tako-tsubo cardiomyopathy was diagnosed by echocardiography and urgent cardiac magnetic resonance imaging. A coronary angiography was not performed because of the absence of myocardial necrosis or ischemia and signs of myocarditis on cardiac magnetic resonance imaging. Conclusion This life-threatening disease should be excluded in the differential diagnosis by comparing the symptoms with those of typical heart failure particularly after use of ergometrine. Introduction Since the first description in 1991 by Dote et al. 1 an increasing number of reports of tako-tsubo cardiomyopathy CMP have been published. This disease is typically seen in postmenopausal women aged from 58 to 77 years 2 . It is also present in

TÀI LIỆU LIÊN QUAN
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.